Abstract
Vasculitis accounts for the presence of lower-extremity ulcers in 20 % of the patients. Inflammation associated with vasculitis compromises or destroys the vessel wall leading to local hemorrhagic or ischemic events. Skin biopsies are gold standard for the diagnosis of cutaneous vasculitis. The morphology depends on the size of the vessel and extent of the vascular bed affected. The treatment depends on the type, nature, and severity of the vasculitis. These ulcers are resistant to conventional therapies. Immune modulation therapy plays an important role along with the standard wound care measures in healing the ulcers.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Herber OR, Schnepp W, Rieger MA. A systematic review on the impact of leg ulceration on patients’ quality of life. Health Qual Life Outcomes. 2007;5:44.
Carlson JA, Ng BT, Chen KR. Cutaneous vasculitis update: diagnostic criteria, classification, epidemiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopathol. 2005;27:504–28.
Thurtle OA, Cawley MI. The frequency of leg ulceration in rheumatoid arthritis: a survey. J Rheumatol. 1983;10(3):507–9.
Chen KR, Toyohara A, Suzuki A, Miyakawa S. Clinical and histopathological spectrum of cutaneous vasculitis in rheumatoid arthritis. Br J Dermatol. 2002;147:905–13.
Mongan ES, Cass RM, Jacox RF, Vaughen JH. A study of the relation of seronegative and seropositive rheumatoid arthritis to each other and to necrotizing vasculitis. Am J Med. 1969;47(1):23–35.
Fries JF, Hunder GG, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Summary. Arthritis Rheum. 1990;33:1135–6.
Acland KM, Darvay A, Wakelin SH, Russell-Jones R. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome? Br J Dermatol. 1999;140(1):131–5.
Suresh E. Diagnostic approach to patients with suspected vasculitis. Postgrad Med J. 2006;82:483–8.
Chen KR. Cutaneous polyarteritis nodosa: a clinical and histopathological study of 20 cases. J Dermatol. 1989;16(6):429–42.
Milstone LM, Braverman IM, Lucky P, Fleckman P. Classification and therapy of atrophie blanche. Arch Dermatol. 1983;119(12):963–9.
Jetton RL, Lazarus GS. Minidose heparin therapy for vasculitis of atrophie blanche. J Am Acad Dermatol. 1983;8(1):23–6.
Della Bella S, Molteni M, Mocellin C, et al. Novel mode of action of iloprost: in vitro down-regulation of endothelial cell adhesion molecules. Prostaglandins Other Lipid Mediat. 2001;65:73–83.
Scott DG, Bacon PA. Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med. 1984;76(3):377–84.
Lapraik C, Watts R, Scott DG. Modern management of primary systemic vasculitis. Clin Med. 2007;7(1):43–7.
Takeuchi A, Hashimoto T. Oral prostaglandin E1 as a therapeutic modality for leg ulcers in Behcet’s disease. Int J Clin Pharmacol Res. 1987;7(4):283–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer India
About this chapter
Cite this chapter
Ramakrishna, P. (2016). Vasculitis and Ulceration. In: Khanna, A., Tiwary, S. (eds) Ulcers of the Lower Extremity. Springer, New Delhi. https://doi.org/10.1007/978-81-322-2635-2_14
Download citation
DOI: https://doi.org/10.1007/978-81-322-2635-2_14
Published:
Publisher Name: Springer, New Delhi
Print ISBN: 978-81-322-2633-8
Online ISBN: 978-81-322-2635-2
eBook Packages: MedicineMedicine (R0)